Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

61.27 USD -0.36 (-0.58%)
Official Closing Price Updated: 7:56 PM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,584,864
Open 61.95
Bid (Size) 61.32 (1)
Ask (Size) 61.34 (1)
Prev. Close 61.63
Today's Range 61.21 - 62.18
52wk Range 45.76 - 67.16
Shares Outstanding 1,634,538,458
Dividend Yield 2.61%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference
Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference 
From Business Wire News Releases
Bristol Myers Squibb Announces Dividend
Bristol Myers Squibb Announces Dividend 
From Business Wire News Releases

Performance

YTD
-0.18%
-0.18%
1 Month
-1.51%
-1.51%
3 Month
-1.83%
-1.83%
6 Month
+0.49%
+0.49%
1 Year
+1.54%
+1.54%

More News

Read More
Are These Top Health Care Stocks Worth Watching Ahead Of March?
Tags Market News
From StockMarket.com
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
From Business Wire News Releases
Bristol Myers Squibb Donates $11 Million to Advance Health Equity
Tags Bristol/Meyers Squibb Improving Healthcare Access Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
7 Value Stocks Ready for the Next 10 Years
Tags BRK/B/NYSE F BUD
From InvestorPlace
Warren Buffett Says Berkshire's Apple Investment Shows The 'Power Of Repurchases'
Tags BRK/A MRK AAPL
From Benzinga
The New England Journal of Medicine Publishes Results from Pivotal Phase 2 KarMMa Study of Idecabtagene Vicleucel (Ide-cel, bb2121), an Investigational BCMA-Directed CAR T Cell Therapy
From Business Wire News Releases
European Medicines Agency's CHMP Backs Approval Of Cabometyx/Opdivo Combo In Kidney Cancer
Tags Biotech BMY Health Care
From Benzinga
3 Top Stocks That'll Make You Richer in March (and Beyond)
Tags BMY FB GOLD
From Motley Fool
5 Deep Value Dividend Stocks For Annual Portfolio Rebalancing
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X